Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis

• Published in: International journal of molecular sciences 2023-06, Vol.24 (13), p.10798
• Main Authors: Salamini-Montemurri, Martín, Lamas-Maceiras, Mónica, Lorenzo-Catoira, Lidia, Vizoso-Vázquez, Ángel, Barreiro-Alonso, Aida, Rodríguez-Belmonte, Esther, Quindós-Varela, María, Cerdán, M Esperanza
• Format: Article
• Language: English
• Subjects: Analysis; Biomarkers; Biomarkers, Tumor - genetics; Cancer; Carcinoma, Ovarian Epithelial - genetics; Carcinoma, Ovarian Epithelial - pathology; Cell Line, Tumor; Deregulation; DNA microarrays; Female; Gene expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes; Genetic aspects; Genetic research; Gynecological cancer; Humans; Medical prognosis; Medical research; Medicine, Experimental; Meta-analysis; Metastases; Metastasis; Non-coding RNA; Nucleotides; Ovarian cancer; Ovarian Neoplasms - metabolism; Patients; Prognosis; RNA; RNA sequencing; RNA, Long Noncoding - metabolism; Trends
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241310798

Epithelial ovarian cancer (EOC) is one of the deadliest gynecological cancers worldwide, mainly because of its initially asymptomatic nature and consequently late diagnosis. Long non-coding RNAs (lncRNA) are non-coding transcripts of more than 200 nucleotides, whose deregulation is involved in pathologies such as EOC, and are therefore envisaged as future biomarkers. We present a meta-analysis of available gene expression profiling (microarray and RNA sequencing) studies from EOC patients to identify lncRNA genes with diagnostic and prognostic value. In this meta-analysis, we include 46 independent cohorts, along with available expression profiling data from EOC cell lines. Differential expression analyses were conducted to identify those lncRNAs that are deregulated in (i) EOC versus healthy ovary tissue, (ii) unfavorable versus more favorable prognosis, (iii) metastatic versus primary tumors, (iv) chemoresistant versus chemosensitive EOC, and (v) correlation to specific histological subtypes of EOC. From the results of this meta-analysis, we established a panel of lncRNAs that are highly correlated with EOC. The panel includes several lncRNAs that are already known and even functionally characterized in EOC, but also lncRNAs that have not been previously correlated with this cancer, and which are discussed in relation to their putative role in EOC and their potential use as clinically relevant tools.